Effect of betablockers on the course of Martorell hypertensive ulcers: a retrospective study
DOI:
https://doi.org/10.2340/actadv.v104.41087Keywords:
ulcers, vascular disorders, hypertension, Martorell, treatmentAbstract
Martorell hypertensive ulcer (MHU) represents a painful, difficult-to-handle condition associated with peri-pheral, subcutaneous arteriolosclerosis caused by chronic hypertensive disease. Betablockers are effective for and widely used to treat hypertensive disease but are reported to exacerbate peripheral vasoconstriction. The effect of betablockers on pre-existing arteriolosclerosis and the course of MHU is, however, unknown. A retrospective study to assess the effect of betablockers on the course and response to treatment of MHU was conducted. Clinical and histopathological data were collected of patients treated for MHU at the authors’ institution between 2014 and 2023 and a side-by-side comparison was performed of patients taking betablockers or not. Analysis focused on MHU severity at presentation, analgesic use, response to therapeutic intervention, and alterations of cutaneous arterioles. The study reports significantly larger ulcers and more frequent use of opioids in patients taking betablockers, while no significant difference was observed in terms of MHU response to treatment. Significantly increased luminal obstruction of peripheral cutaneous arterioles was found in patients taking beta-blockers. Based on these data, betablockers may have a negative effect on the course of MHU and should be carefully assessed in patients with MHU.
Downloads
References
Farber EM, Hines EA, Jr., Montgomery H, McK Craig W. The arterioles of the skin in essential hypertension. J Invest Dermatol 1947; 9: 285-298.
https://doi.org/10.1038/jid.1947.101 DOI: https://doi.org/10.1038/jid.1947.101
Vuerstaek JD, Reeder SW, Henquet CJ, Neumann HA. Arteriolosclerotic ulcer of Martorell. J Eur Acad Dermatol Venereol 2010; 24: 867-874.
https://doi.org/10.1111/j.1468-3083.2009.03553.x DOI: https://doi.org/10.1111/j.1468-3083.2009.03553.x
Alavi A, Mayer D, Hafner J, Sibbald RG. Martorell hypertensive ischemic leg ulcer: an underdiagnosed Entity. Adv Skin Wound Care 2012; 25: 563-572.
https://doi.org/10.1097/01.ASW.0000423442.08531.fb DOI: https://doi.org/10.1097/01.ASW.0000423442.08531.fb
Martorell F. Hypertensive ulcer of the leg. J Cardiovasc Surg 1978; 19: 599-600.
Hafner J, Nobbe S, Partsch H, Läuchli S, Mayer D, Amann-Vesti B, et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol 2010; 146: 961-968.
https://doi.org/10.1001/archdermatol.2010.224 DOI: https://doi.org/10.1001/archdermatol.2010.224
Reeder SW, Middelburg TA, Neumann HA. An extremely painful ulcer on the lower leg; Martorell arteriolosclerotic ulcer. Ned Tijdschr Geneeskd 2009; 153: B421.
Woolling KR. Hypertensive-ischemic ulcer. An atypical ischemic necrosis of the skin. Jama 1964; 187: 196-201.
https://doi.org/10.1001/jama.1964.03060160024006 DOI: https://doi.org/10.1001/jama.1964.03060160024006
Duncan HJ, Faris IB. Martorell's hypertensive ischemic leg ulcers are secondary to an increase in the local vascular resistance. J Vasc Surg 1985; 2: 581-584. DOI: https://doi.org/10.1067/mva.1985.avs0020581
https://doi.org/10.1016/0741-5214(85)90013-8 DOI: https://doi.org/10.1016/0741-5214(85)90013-8
Deinsberger J, Brugger J, Tschandl P, Meier-Schiesser B, Anzengruber F, Bossart S, et al. Differentiating Arteriolosclerotic Ulcers of Martorell from Other Types of Leg Ulcers Based on Vascular Histomorphology. Acta Derm Venereol 2021; 101: adv00449.
https://doi.org/10.2340/00015555-3804 DOI: https://doi.org/10.2340/00015555-3804
Deinsberger J, Moschitz I, Marquart E, Manz-Varga AK, Gschwandtner ME, Brugger J, et al. Development of a localization-based algorithm for the prediction of leg ulcer etiology. J Dtsch Dermatol Ges 2023; 21: 1339-1349.
https://doi.org/10.1111/ddg.15192 DOI: https://doi.org/10.1111/ddg.15192
Romanelli MR, Thayer JA, Neumeister MW. Ischemic Pain. Clin Plast Surg 2020; 47: 261-265.
https://doi.org/10.1016/j.cps.2019.11.002 DOI: https://doi.org/10.1016/j.cps.2019.11.002
Weber B, Deinsberger J, Hafner J, Beltraminelli H, Tzaneva S, Böhler K. Localization-mapping of arteriolosclerotic ulcers of Martorell using two-dimensional computational rendering reveals a predominant location on the mid-lateral lower leg. J Eur Acad Dermatol Venereol 2021; 35: e40-e42.
https://doi.org/10.1111/jdv.16787 DOI: https://doi.org/10.1111/jdv.16787
Choucair MM, Fivenson DP. Leg ulcer diagnosis and management. Dermatol Clin 2001; 19: 659-678.
https://doi.org/10.1016/S0733-8635(05)70307-7 DOI: https://doi.org/10.1016/S0733-8635(05)70307-7
Csuka EA, Ward SC, Ekelem C, Csuka DA, Ardigò M, Mesinkovska NA. Reflectance Confocal Microscopy, Optical Coherence Tomography, and Multiphoton Microscopy in Inflammatory Skin Disease Diagnosis. Lasers in Surgery and Medicine 2021; 53: 776-797.
https://doi.org/10.1002/lsm.23386 DOI: https://doi.org/10.1002/lsm.23386
Malhi HK, Didan A, Ponosh S, Kumarasinghe SP. Painful Leg Ulceration in a Poorly Controlled Hypertensive Patient: A Case Report of Martorell Ulcer. Case Rep Dermatol 2017; 9: 95-102.
https://doi.org/10.1159/000468977 DOI: https://doi.org/10.1159/000468977
Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 2012; 8: 469-479.
https://doi.org/10.1038/nrrheum.2012.96 DOI: https://doi.org/10.1038/nrrheum.2012.96
Lacourcière Y, Lefebvre J, Provencher P, Poirier L. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring. Br J Clin Pharmacol 1993; 35: 121-127.
https://doi.org/10.1111/j.1365-2125.1993.tb05677.x DOI: https://doi.org/10.1111/j.1365-2125.1993.tb05677.x
Brand FN, Larson MG, Kannel WB, McGuirk JM. The occurrence of Raynaud's phenomenon in a general population: the Framingham Study. Vasc Med 1997; 2: 296-301.
https://doi.org/10.1177/1358863X9700200404 DOI: https://doi.org/10.1177/1358863X9700200404
Khouri C, Jouve T, Blaise S, Carpentier P, Cracowski JL, Roustit M. Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis. Br J Clin Pharmacol 2016; 82: 549-560.
https://doi.org/10.1111/bcp.12980 DOI: https://doi.org/10.1111/bcp.12980
Marshall AJ, Roberts CJ, Barritt DW. Raynaud's phenomenon as side effect of beta-blockers in hypertension. Br Med J 1976; 1: 1498-9.
https://doi.org/10.1136/bmj.1.6024.1498 DOI: https://doi.org/10.1136/bmj.1.6024.1498
Feldman AT, Wolfe D. Tissue processing and hematoxylin and eosin staining. Methods Mol Biol 2014; 1180: 31-43.
https://doi.org/10.1007/978-1-4939-1050-2_3 DOI: https://doi.org/10.1007/978-1-4939-1050-2_3
Tu T-Y, Chao PC-P. Continuous blood pressure measurement based on a neural network scheme applied with a cuffless sensor. Microsyst Technol 2018; 24: 4539-4549.
https://doi.org/10.1007/s00542-018-3957-4 DOI: https://doi.org/10.1007/s00542-018-3957-4
Yang A, Yu G, Wu Y, Wang H. Role of β2-adrenergic receptors in chronic obstructive pulmonary disease. Life Sci 2021; 265: 118864.
https://doi.org/10.1016/j.lfs.2020.118864 DOI: https://doi.org/10.1016/j.lfs.2020.118864
Ubbink DT, Verhaar EE, Lie HK, Legemate DA. Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease. J Vasc Surg 2003; 38: 535-540.
https://doi.org/10.1016/S0741-5214(03)00419-1 DOI: https://doi.org/10.1016/S0741-5214(03)00419-1
Paravastu SC, Mendonca DA, Da Silva A. Bêta-bloquants pour la maladie artérielle périphérique. Cochrane Database Syst Rev 2013; 2013: CD005508.
https://doi.org/10.1002/14651858.CD005508.pub3 DOI: https://doi.org/10.1002/14651858.CD005508.pub3
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Lucy Cleusix, Olesya Pavlova, Emmanuella Guenova, François Kuonen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
